Personalized Addiction Treatment eHancement

Sex: All

Ages: 22 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 40

Sponsor: Rhode Island Hospital

Summary

Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk population.

Eligibility Criteria

Inclusion Criteria: * Age 22+ * Current Opioid Use Disorder diagnosis * Prescribed buprenorphine or methadone * Initiated or reinitiated buprenorphine or methadone treatment recently * Access to personal smartphone Exclusion Criteria: * Not fluent in English * Limited mental capacity or inability to provided informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07778394). StuddyBuddy aggregates publicly available trial information.